HomePLRX • NASDAQ
add
Pliant Therapeutics Inc
Previous close
$1.46
Day range
$1.39 - $1.51
Year range
$1.10 - $16.52
Market cap
86.55M USD
Avg Volume
988.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 58.94M | 12.49% |
Net income | -56.17M | -19.62% |
Net profit margin | — | — |
Earnings per share | -0.92 | -17.95% |
EBITDA | -58.49M | -12.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 305.64M | -36.64% |
Total assets | 344.77M | -33.90% |
Total liabilities | 87.61M | 3.96% |
Total equity | 257.16M | — |
Shares outstanding | 61.39M | — |
Price to book | 0.35 | — |
Return on assets | -39.73% | — |
Return on capital | -43.23% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -56.17M | -19.62% |
Cash from operations | -48.86M | -61.42% |
Cash from investing | 69.11M | 16.07% |
Cash from financing | 498.00K | -97.71% |
Net change in cash | 20.75M | -59.37% |
Free cash flow | -41.40M | -127.76% |
About
Founded
2015
Headquarters
Website
Employees
171
